Soluble SIGLEC1 as a biomarker of disease activity in idiopathic inflammatory myopathies

20260 citationsJournal Article

Authors

Nathan Barreth · University of Calgary

V. Leclair · McGill University

Marie Hudson · McGill University

Sasha Bernatsky · McGill University

Eugene Krustev · University of Calgary

Cristina Moran Toro · University of Calgary

Yvan St. Pierre ·

Abstract

scSIGLEC1 levels are a promising biomarker for monitoring overall IIM disease activity, as well as activity involving the cutaneous, musculoskeletal, and gastrointestinal systems.

Topics & Keywords

Inflammatory Myopathies and Dermatomyositis Skin Diseases and Diabetes Spondyloarthritis Studies and Treatments

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: Lara D. Veeken

DOI: 10.1093/rheumatology/keag139

Field-Weighted Citation Impact: 0.00